Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis

Journal of the American Academy of Dermatology

Volumn 42, Issue 1 I, 2000, Pages 70-75

  Yazawa, Norihito ^a   Kikuchi, Kanako ^a   Ihn, Hironobu ^a   Fujimoto, Manabu ^a   Kubo, Masahide ^a   Tamaki, Takeshi ^a   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; GELATINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADOLESCENT; ADULT; AGED; BLOOD LEVEL; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; EXTRACELLULAR MATRIX; FEMALE; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; SCLERODERMA; SYSTEMIC SCLEROSIS;

EID: 0033927206     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(00)90011-2     Document Type: Article

References (20)

1. LeRoy EC. Increased collagen synthesis by scleroderma fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast. J Clin Invest 1974;54:880-9.
2. Takeda K, Hatamochi A, Ueki H,Nakata M, Oishi Y. Decreased collagenase expression in cultured systemic sclerosis fibroblasts. J Invest Dermatol 1994;103:359-63.
3. Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T. Rapid one-step sandwich enzyme immno assay for tissue inhibitor of metalloproteinases: an application for rheumatoid arthritis serum and plasma. J Immnol Methods 1990;127:103-8.
4. Kikuchi K, Kubo M, Sato S, Fujimoto M, Tamaki K. Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis. J Am Acad Dermatol 1995;33:973-8.
5. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
6. LeRoy EC, Krieg T, Black C, Medsger TA Jr, Fleischmajer R, Rowell N, et al. Scleroderma (systemic sclerosis): classification, subset, and pathogenesis. J Rheumatol 1988;15:202-5.
7. Barnett AJ. Scleroderma: progress and course based on a personal series of 118 cases. Med J Aust 1978;2:129-34.
8. Fiocco U, Rosada M, Cozzi L, Ortolani C, Silvestro GD, Ruffatti A, et al. Early phenotypic activation of circulating helper memory T cell in scleroderma: correlation disease activity. Ann Rheum Dis 1993;52:272-7.
9. Steen VD, Powell DL, Medsger TA Jr. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988;31:196-203.
10. Fujimoto M, Sato S, Ihn H, Kikuchi K, Tamaki K, Takehara K. Autoantibodies to pyruvate dehydrogenase complex in patients with systemic sclerosis. Arthritis Rheum 1995;38:985-9.
11. Baker T, Tickle S, Wasan H, Docherty A, Isenberg D, Waxman J. Serum metalloproteinases and their inhibitor: markers for malignant potential. Br J Cancer 1994;70:506-12.
12. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis:an imbalance of positive and negative regulation. Cell 1991;64:327-36.
13. Stetler-Stevenson WG, Krutzsch HC, Liotta LA. Tissue inhibitor of metalloproteinase (TIMP-2). J Biol Chem 1989;264:17374-8.
14. Mattila L, Airola K, Ahonen M, Hietarinta M, Black C, Saarialho-Kere U, et al. Activation of tissue inhibitor of metalloproteinases-3 mRNA expression in scleroderma skin fibroblasts. J Invest Derm 1998;110:416-21.
15. Ishiguro N, Ito T, Obata K, Fujimoto N, Iwata H. Determination of stromelysin-1,72 and 92 kDa type IV collagenase, tissue inhibitor of metallproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis. J Rheum 1996;23:1599-604.
16. Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta LA. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 1990;265:13933-8.
17. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. FEBS Lett 1992; 298:29-32.
18. Kikuchi K, Kadono T, Furue M, Tamaki K. Tissue inhibitor of metalloproteinase (TIMP-1) may be an autocrine growth factor in scleroderma fibroblasts. J Invest Dermatol 1997;108:281-4.
19. Stetler-Stevenson WG, Bersch N, Gold DW. Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity. FEBS Lett 1992;296:231-4.
20. Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci 1994;107:2373-9.